Source: Eur Respir J 2003; 21: 267-272
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Witek T.J., Mahler D.A.. Minimal important difference of the transition dyspnoea index in a multinational clinical trial. Eur Respir J 2003; 21: 267-272

Member's Comments

No comment yet.

Related content which might interest you: The derivation of a new index of severity for COPD patients, the DOSE index: MRC dyspnea scale, airflow obstruction, smoking status and exacerbations Source: Annual Congress 2007 - Predicting factors of patients undergoing rehabilitation Year: 2007 Symptom variability in patients with severe COPD: a pan-European cross-sectional study Source: Eur Respir J 2011; 37: 264 Year: 2011 Dyspnoea Source: Respipedia Article Year: 2016 The minimal important difference of exercise tests in severe COPD Source: Eur Respir J 2011; 37: 784-790 Year: 2011 Interpreting thresholds for a clinically significant change in health status in asthma and COPD Source: Eur Respir J 2002; 19: 398-404 Year: 2002 A therapeutic arteriovenous fistula not only improves exercise tolerance, but also BODE index in patients with severe COPD Source: Annual Congress 2007 - Treatment and care of COPD Year: 2007 A 70-year-old patient with COPD, progressive dyspnea and haemoptysis Source: Annual Congress 2006 - Oncology Grand Round: an interactive session Year: 2006 Memory for symptoms in COPD patients: how accurate are their reports? Source: Eur Respir J 2001; 18: 474-481 Year: 2001 A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease Source: Eur Respir J 2002; 19: 217-224 Year: 2002 Fatigue in COPD: association with functional status and hospitalisations Source: Eur Respir J 2013; 41: 565-570 Year: 2013 Tiotropium as essential maintenance therapy in COPD Source: Eur Respir Rev 2006; 15: 51-57 Year: 2006 A physiological model of patient-reported breathlessness during daily activities in COPD Source: Eur Respir Rev 2009; 18: 66-79 Year: 2009 Predictive accuracy of patient-reported exacerbation frequency in COPD Source: Eur Respir J 2011; 37: 501-507 Year: 2011 Regional differences in the treatment of patients with moderate COPD enrolled in a global clinical trial Source: Annual Congress 2006 - Recent advances in the treatment of COPD Year: 2006 The body-mass index, airflow obstruction, dyspnea, and exercise capacity (BODE) index in Filipino patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2005; 26: Suppl. 49, 57s Year: 2005 Baseline self-reported comorbidity in COPD patients referred for pulmonary rehabilitation (PR) Source: Annual Congress 2006 - COPD comorbidity Year: 2006 Impact of chronic airflow obstruction in a working population Source: Eur Respir J 2008; 31: 1227-1233 Year: 2008 The availibility of copd assessment test (CAT) in determination of risk of early hospitalization in chronic obstructive pulmonary disease patients and its correlation with pulmonary function tests, dyspnea measurement scales and St George respiratory questionnaire Source: International Congress 2014 – COPD markers Year: 2014 A randomised controlled trial of individualised, progressed early exercise in patients hospitalised with an acute exacerbation of chronic obstructive pulmonary disease (AECOPD) Source: International Congress 2015 – Latest insights in pulmonary rehabilitation and functional capacity Year: 2015